Class Action Lawsuit Challenges Ban on Gender Affirming Care for Federal Employees

Class Action Lawsuit Challenges Ban on Gender Affirming Care for Federal Employees
  • calendar_today August 7, 2026
  • News

A major legal battle over gender affirming care is unfolding in Washington, D.C., as the Human Rights Campaign Foundation, together with law firms Correia & Puth and Cohen Milstein Sellers & Toll, has filed a class action lawsuit against the federal government. The suit challenges the recent prohibition on health insurance coverage for gender-affirming care for federal employees enrolled in Federal Employees Health Benefits and Postal Service Health Benefits plans.

Policy at the Center of Federal Lawsuit

The controversial policy, initiated by the Office of Personnel Management and set to take effect on January 1, 2026, eliminates coverage for gender affirming care under the affected insurance plans. Plaintiffs allege that this action constitutes discrimination based on sex, violating Title VII and potentially impacting thousands of current and former federal employees in Washington, D.C. and across the country.

Human Rights Campaign Leads Legal Challenge

The Human Rights Campaign (HRC), a leading LGBTQ advocacy organization, has taken a prominent role in contesting the ban. HRC President Kelley Robinson characterized the policy as “blatant discrimination,” pledging the organization will fight vigorously in court. The class action, with support from law firms experienced in civil rights litigation, brings the issue of lgbtq discrimination to the forefront of national attention.

Scope of the Ban’s Impact

Research cited in the complaint suggests that at least 39,400 current and former federal employees and their families could lose vital access to gender affirming healthcare if the policy stands. The lawsuit seeks to restore health insurance coverage and ensure that federal workers are not denied medically necessary treatments for gender dysphoria and related conditions. Many medical organizations have affirmed that such care is evidence-based and essential for the health and wellbeing of transgender individuals.

Connections to the Trump Administration Policy

The challenged ban is widely seen as part of a broader policy approach from the Trump administration—now under the Trump-Vance leadership—intended to roll back transgender healthcare access. Civil rights advocates assert that these moves ignore the prevailing stance among major medical bodies and set a concerning precedent for employment-related benefits in the federal sector.

Title VII and Protections Against Discrimination

Key to the plaintiffs’ argument is Title VII discrimination, which prohibits employment discrimination based on sex, race, color, national origin, and religion. The Human Rights Campaign and its legal partners argue that denying gender affirming care through federal employees health benefits amounts to sex-based discrimination under federal law. This focus echoes recent federal court decisions recognizing that protections against sex discrimination extend to transgender individuals.

Broader Legal and Political Implications

The federal lawsuit adds momentum to a series of ongoing legal actions challenging attempts to curtail transgender healthcare rights. As attention intensifies in Washington, D.C., the outcome of this case could shape future health insurance coverage and workplace protections for LGBTQ federal employees.

Community and Institutional Response

Advocacy groups and local institutions across Washington, D.C. have voiced support for efforts aimed at preserving transgender healthcare access. Many in the region view the lawsuit as an important stand against perceived federal overreach and as a defense of equality within government employee benefits frameworks. The case reflects persistent tensions among policy, law, and the lived realities of federal workers navigating the changing landscape of healthcare rights.

As the class action lawsuit proceeds, all eyes in Washington, D.C. and beyond remain on the courts, which are set to decide the future of gender affirming care for the nation’s federal workforce and their families.